Let There Be Light: A spotlight on Kiora’s Flagship Product, KIO-301, which Aims to Restore Vision for Patients with a Rare Inherited Retinal Disease

Dear Friends and Shareholders,

We want to share with you a review of our promising pipeline product, KIO-301, being developed for the treatment of the inherited retinal disease, Retinitis Pigmentosa - Spotlight on KIO-301

Regards,

Kiora Pharma

Released August 2, 2023